Aimmune Therapeutics announced the approval of PALFORZIA™ by the U.S. Food and Drug Administration (FDA), making it the first approved treatment for patients with peanut allergy.

PALFORZIA is a biologic drug for peanut oral immunotherapy (OIT) for children 4-17 years of age. With OIT, small amounts of the allergen are given by mouth in gradually increasing doses until the patient is able to eat a certain amount of it without having a reaction so long as they are on this treatment.

Although PALFORZIA is available in the U.S. only right now, we want to hear your thoughts on this news. Tell us what you think below:

What are your thoughts on PALFORZIA and on OIT in general?

Is your family currently undergoing OIT? If not, is it something you would consider doing?

If you would like to share your experiences with us on doing OIT or any other forms of immunotherapy for food allergy, please complete this form and we’ll reach out to you. Your personal stories help immensely with our advocacy efforts for the advancement of therapies.

First name:

Last name:

Email:

Phone number:

Province:

British ColumbiaAlbertaSaskatchewanManitobaOntarioQuebecNew BrunswickNova ScotiaPrince Edward IslandNewfoundland and LabradorYukonNorthwest TerritoriesNunavutOther

Share your story:

Thank you for taking the time to complete this survey! Your input helps us better understand your priorities and informs our advocacy efforts.